20.05
+0.19
+(0.96%)
As of 2:47:56 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
65,018.00
50,333.00
41,372.00
Operating Income
-65,018.00
-50,333.00
-41,372.00
Net Non Operating Interest Income Expense
6,604.00
2,769.00
1,132.00
Other Income Expense
698.00
301.00
--
Pretax Income
-57,716.00
-47,263.00
-40,240.00
Net Income Common Stockholders
-57,716.00
-47,263.00
-40,240.00
Diluted NI Available to Com Stockholders
-57,716.00
-47,263.00
-40,240.00
Basic EPS
-1.42
-1.87
-0.99
Diluted EPS
-1.42
-1.87
-0.99
Basic Average Shares
40,614.31
25,324.47
40,614.31
Diluted Average Shares
40,614.31
25,324.47
40,614.31
Total Operating Income as Reported
-65,018.00
-50,333.00
-41,372.00
Total Expenses
65,018.00
50,333.00
41,372.00
Net Income from Continuing & Discontinued Operation
-57,716.00
-47,263.00
-40,240.00
Normalized Income
-57,716.00
-47,263.00
-40,240.00
Interest Income
6,604.00
2,769.00
1,132.00
Net Interest Income
6,604.00
2,769.00
1,132.00
EBIT
-65,018.00
-50,333.00
-41,372.00
EBITDA
-64,356.00
-49,750.00
-41,250.00
Reconciled Depreciation
662.00
583.00
122.00
Net Income from Continuing Operation Net Minority Interest
-57,716.00
-47,263.00
-40,240.00
Normalized EBITDA
-64,356.00
-49,750.00
-41,250.00
12/31/2022 - 2/7/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAZE Maze Therapeutics, Inc.
11.79
-1.58%
MTSR Metsera, Inc.
30.05
-5.07%
ALMS Alumis Inc.
5.17
+2.78%
ANAB AnaptysBio, Inc.
18.67
+15.60%
THRD Third Harmonic Bio, Inc.
3.4450
-2.96%
MBX MBX Biosciences, Inc.
8.94
-0.89%
SLRN Acelyrin, Inc.
2.0900
+4.51%
BCAX Bicara Therapeutics Inc.
12.97
-1.89%
UPB Upstream Bio, Inc.
7.66
+6.98%
PLRX Pliant Therapeutics, Inc.
3.3850
+24.45%